References
Derebek E, Kirkali Z, Dogan AS, Degirmenci B, Yilmaz M, Igci E, Yorukoglu K, Kovanlikaya I, Durak H.99mTc-MIBI scintigraphy in metastatic renal cell carcinoma: clinical validation of the relationship between99mTc-MIBI uptake and Pglycoprotein expression in tumour tissue.Eur J Nucl Med 1996; 23: 976–979.
Diggles L, Mena I, Khalkhali I. Technical aspects of prone dependent-breast scintimammography.J Nucl Med Technol 1994; 22: 165–170.
Moretti J-L, Azaloux H, Boisseron D, Kouyoumdjian J-C, Vilcoq J. Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glyocprotein overexpression.Eur J Nucl Med 1996; 23: 980–986.
Mankoff DA, Gralow JR, Dunnwald LK, Druker MJ, Ellis G, Livingstone RB. [Tc-99m]-sestaMIBI scintimammography to measure response to neo-adjuvant chemotherapy.J Nucl Med 1996; 37: 252P.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Croasdale, I.R., Buscombe, J.R. & Hilson, A.J.W. 99mTc-MIBI uptake in metastatic renal cell carcinoma. Eur J Nucl Med 24, 88 (1997). https://doi.org/10.1007/BF01728317
Issue Date:
DOI: https://doi.org/10.1007/BF01728317